Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
918.52
-2.97 (-0.32%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
98
99
Next >
Chart Of The Day: Eli Lilly - More New Highs
June 26, 2024
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide.
Via
Talk Markets
The Next 7 Trillion-Dollar Stocks to Buy: June 2024 Edition
June 26, 2024
The next trillion dollar stocks have emerged in a few key areas that investors should understand in greater detail in order to profit.
Via
InvestorPlace
Better Growth Stock: Archer Aviation or Viking Therapeutics?
June 26, 2024
Which one of these potential disruptors is the better buy?
Via
The Motley Fool
2 Reasons Why Eli Lilly's Stock Likely Hasn't Peaked
June 26, 2024
The stock may seem expensive right now, but that may not be the case in a few years.
Via
The Motley Fool
Alphabet Among Stocks Hitting All-Time High Tuesday: See Which Stocks Just Came On IBD's Top Stock Screens
June 25, 2024
Google-parent Alphabet hit a fresh high at 184.03 Tuesday. Its earnings rose the past year to a 53% surge to $1.74 per share last quarter.
Via
Investor's Business Daily
Novo Nordisk's Older Generation Weight-Loss Drug Saxenda Associated With Decreased Bone Mass Density, Study Shows
June 25, 2024
Novo Nordisk's Saxenda study published in JAMA Network Open reveals significant declines in bone density among patients, raising concerns for similar weight loss drugs.
Via
Benzinga
This Is What Whales Are Betting On Eli Lilly and Co
June 25, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 25, 2024
Via
Benzinga
What's Going On With Eli Lilly Stock On Tuesday?
June 25, 2024
Eli Lilly collaborates with Microsoft-backed OpenAI to leverage generative AI for developing novel antimicrobials targeting drug-resistant pathogens. This partnership supports Lilly's commitment to...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
NVO Stock: Novo Nordisk Pops as China Approves Wegovy Weight Loss Drug
June 25, 2024
Novo Nordisk and Eli Lilly dominate the market for GLP-1 drugs, and are racing ahead to produce more of them.
Via
InvestorPlace
1 Supercharged Vanguard Index Fund to Buy Before It Soars 174%, According to a Wall Street Analyst
June 25, 2024
The Vanguard S&P 500 ETF includes many of the most influential stocks in the world, such as Microsoft, Apple, Nvidia, Alphabet, and Amazon.
Via
The Motley Fool
Topics
ETFs
Stocks
Exposures
US Equities
What's Going On With Eli Lilly Shares Monday?
June 24, 2024
Eli Lilly and Co (NYSE: LLY) shares are moving higher Monday following the release of positive Phase 3 trial results for its weight loss drug, tirzepatide, marketed as Zepbound.
Via
Benzinga
Why ResMed Shares Are Trading Lower Monday
June 24, 2024
ResMed stock is trading lower Monday after Eli Lilly and Company released data from a clinical trial in regards to the treatment of sleep apnea.
Via
Benzinga
Will Novo Nordisk Building Fires Serve As A Catalyst For Eli Lilly? Redditors See A Stock Split For US Company 'Very Likely'
June 24, 2024
Eli Lilly's stock may rise due to supply issues at competitor Novo Nordisk, according to Reddit users. Its weight loss drug and upcoming FDA approval are also factors. Investors are optimistic about...
Via
Benzinga
Exposures
Product Safety
10 Health Care Stocks Whale Activity In Today's Session
June 24, 2024
Via
Benzinga
ALT Stock Alert: Altimmune Pops on Weight-Loss Drug Findings
June 24, 2024
Altimmune (ALT) stock is soaring and trending after the company reported data on its GLP-1 weight-loss drug today.
Via
InvestorPlace
Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again
June 24, 2024
Eli Lilly tested its weight-loss drug in people with obesity suffering from sleep apnea events.
Via
Investor's Business Daily
Eli Lilly's Zepbound For Weight Loss Shows Disease Resolution In Obese Sleep Apnea Patients, Lays Further Groundwork For Label Expansion
June 24, 2024
Eli Lilly's phase 3 SURMOUNT-OSA trials show tirzepatide injection significantly reduces apnea events in adults with obesity and moderate-to-severe obstructive sleep apnea. FDA decision expected by end...
Via
Benzinga
Exposures
Product Safety
AbbVie Inc. Dividend Stock Analysis - Saturday, June 22
June 22, 2024
Here are some highlights from a detailed, quantitative analysis AbbVie Inc. stock. Let's take a closer look at various factors, such as the stock's value and dividend.
Via
Talk Markets
3 Biotech Stocks to Buy Now: June 2024
June 21, 2024
These are the three best biotech stocks to buy for long-term returns and portfolio stability due to their target patient populations,
Via
InvestorPlace
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
Gilead Sciences faces Wall Street speculation about its potential in the obesity drug market despite its focus on liver treatments.
Via
Benzinga
Lawsuit Could Challenge Trust In Ozempic And Other Popular Weight Loss Drugs
June 21, 2024
Weight loss drug manufacturers Novo Nordisk and Eli Lilly are being challenged in court. The companies are accused of failing to properly warn patients about associated risks.
Via
Talk Markets
Topics
Lawsuit
Exposures
Financial
Legal
Pre-Market Movers - June 21, 2024
June 21, 2024
Sarepta jumps after announcing expanded approval of DMD drug and more news on today's top movers.
Via
Talk Markets
Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss
June 21, 2024
As per the official press release, the 16-week trial aimed to evaluate the safety, tolerability, and clinical effects of the drug called petrelintide.
Via
Benzinga
Hype Busters: 3 Overvalued Stocks Ready for a Reality Check
June 21, 2024
Discover three overvalued stocks that have completely lost touch with reality, with growth assumptions destined for disappointment.
Via
InvestorPlace
Nestle Carefully Targets Weight-Loss Drug Users with New Food Line
June 21, 2024
Nestle's new Vital Pursuit brand targets individuals on weight-loss drugs without mentioning medications on packaging, addressing regulatory concerns and focusing on marketing through social media.
Via
Benzinga
Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead
June 21, 2024
Lilly is a good pick...but this one is better.
Via
The Motley Fool
Eli Lilly Has a New Drug That Could Push the Stock Higher
June 20, 2024
The Alzheimer’s treatment market is large and expected to grow.
Via
The Motley Fool
German Drug Developer Evotec Seeks Adviser Input As Takeover Concerns Mount
June 20, 2024
Evotec consults defense advisers following a significant share price decline, raising concerns about a potential takeover.
Via
Benzinga
Wall Street Favorites: 7 Growth Stocks With Strong Buy Ratings for June 2024
June 20, 2024
Investors hunting for stocks that will provide big gains should consider these top-rated growth stocks that have upside potential.
Via
InvestorPlace
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
98
99
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.